AMRI: Albany Molecular Research, Inc. Yearly Stock Returns

Year	Beginning Price	Ending Price	Gain or Loss	Percent Gain or Loss
2000	30.50	123.25*	92.75	304.10%
2001	61.625	26.49	-35.135	-57.01%
2002	26.49	14.79	-11.70	-44.17%
2003	14.79	15.01	0.22	1.49%
2004	15.01	11.14	-3.87	-25.78%
2005	11.14	12.15	1.01	9.07%
2006	12.15	10.56	-1.59	-13.09%
2007	10.56	14.38	3.82	36.17%
2008	14.38	9.74	-4.64	-32.27%
2009	9.74	9.08	-0.66	-6.78%
2010	9.08	5.62	-3.46	-38.11%
2011	5.62	2.93	-2.69	-47.86%
2012	2.93	5.28	2.35	80.20%
2013	5.28	10.08	4.80	90.91%
2014	10.08	16.28	6.20	61.51%
2015	16.28	19.85	3.57	21.93%
2016	19.85	18.76	-1.09	-5.49%
2017	18.76	21.75*	2.99	15.94%

*The 2000 ending price of Albany Molecular Research has been adjusted for a 2 for 1 stock split.
*In 2017, Albany Molecular Research (AMRI) was acquired by the Carlyle Group for $21.75 per share.

Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).